Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amcad BiomedROCO:4188 +1.11%47 Days Inventory is 780.25 as of Mar. 2026, which is 126% above its 10-year median of 345.34. GuruFocus rates ROCO:4188 with a GF Score™ of 47/100 and a GF Value™ of NT$9.60 (Fairly Valued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Amcad Biomed ranks worse than 91.73% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Amcad Biomed's Average Total Inventories for the
three
months ended in Mar. 2026 was NT$27.99 Mil. Amcad Biomed's Cost of Goods Sold for the
three
months ended in Mar. 2026 was NT$3.27 Mil.
Hence, Amcad Biomed's Days Inventory for the
three
months ended in Mar. 2026 was 780.25.
The historical rank and industry rank for Amcad Biomed's Days Inventory or its related term are showing as below:
ROCO:4188'
s Days Inventory Range Over the Past 10 Years
Min: 147.61 Med: 345.34 Max: 544.71
Current: 544.71
During the past 13 years, Amcad Biomed's highest Days Inventory was 544.71. The lowest was 147.61. And the median was 345.34.
ROCO:4188's Days Inventory is ranked worse than 91.73% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 176.385
vs ROCO:4188: 544.71
Amcad Biomed's Days Inventory
increased
from Mar. 2025 (613.49) to Mar. 2026 (780.25).
It might indicate that Amcad Biomed's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amcad Biomed's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amcad Biomed's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 4.38.
Amcad Biomed (ROCO:4188) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amcad Biomed's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amcad Biomed's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amcad Biomed Days Inventory Related Terms
Amcad Biomed Days Inventory Historical Data
* Premium members only.
The historical data trend for Amcad Biomed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4188 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Amcad Biomed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amcad Biomed Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Amcad Biomed's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amcad Biomed's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amcad Biomed (ROCO:4188) has a Days Inventory of 780.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amcad Biomed and its competitors. This is 126% above median its historical median of 345.34. Over the past decade, Amcad Biomed's Days Inventory has ranged from 147.61 to 544.71. According to the industry distribution chart, Amcad Biomed ranks #721 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is Amcad Biomed's Days Inventory too high?
Amcad Biomed's current Days Inventory of 780.25 is 126% above median its 10-year median of 345.34. Over the past 10 years, this metric has ranged from a low of 147.61 to a high of 544.71. The Medical Devices & Instruments industry median Days Inventory is 176.39. Amcad Biomed's value of 780.25 is 342.4% above this industry median. Based on the distribution chart, Amcad Biomed ranks #721 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Amcad Biomed has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Amcad Biomed's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Amcad Biomed ranks #721 out of 786 companies for Days Inventory. This places Amcad Biomed in the lower half of its industry. The industry median Days Inventory is 176.39. Amcad Biomed's value of 780.25 is 342.4% above this benchmark. Historically, Amcad Biomed's own Days Inventory has ranged from 147.61 to 544.71 over the past decade. While the company's 10-year median is 345.34 vs. the industry median of 176.39, Amcad Biomed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.39, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amcad Biomed's current Days Inventory of 780.25 is 342.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amcad Biomed and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amcad Biomed's current Days Inventory is 780.25, which is 126% above median its own 10-year median of 345.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amcad Biomed stock overvalued right now?
Based on GuruFocus' analysis, Amcad Biomed (ROCO:4188) is currently considered Fairly Valued. The stock's GF Value™ is NT$9.60, compared to a current price of NT$10.05 — trading 4.7% above its estimated fair value. The current Days Inventory is 780.25, which is 126% above median its 10-year median of 345.34 and 342.4% above the Medical Devices & Instruments industry median of 176.39. Amcad Biomed's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Amcad Biomed (ROCO:4188), the current Days Inventory is 780.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amcad Biomed (ROCO:4188) Overvalued in 2026?
Based on GuruFocus' analysis, Amcad Biomed stock appears to be overvalued.
The current stock price of NT$10.05 is trading 4.7% above its estimated GF Value™ of NT$9.60.
GuruFocus considers Amcad Biomed to be Fairly Valued.
Key valuation signals for ROCO:4188:
Days Inventory: 780.25 (126% above median its 10-year median of 345.34)
GF Value™: NT$9.60 vs. price of NT$10.05 (4.7% above fair value)
Industry Position: 342.4% above the Medical Devices & Instruments median (#721 of 786)
No single metric tells the full story. See the ROCO:4188 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. Geographically, the company generates revenue from Taiwan, China, Europe, Asia (excluding Taiwan and China), and other countries, out of which the majority of the revenue is generated from Taiwan. The company has two segments: the Medical Diagnostic Software segment, which is responsible for the development and sales of smart medical imaging diagnostic software devices, and the Precision Medical Equipment segment, which is responsible for research, development, manufacturing, and sales of high-end ultrasonic probes. The company generates the majority of its revenue from the Precision Medical Equipment segment.
47GF Score
Get the complete analysis for ROCO:4188
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4188 has been successfully added to your 
